investigating intrinsic and extrinsic factors associated with als
Published 4 years ago • 235 plays • Length 28:57Download video MP4
Download video MP3
Similar videos
-
26:00
2020 symposium on als: brian kraemer, phd, northwestern university
-
20:57
targeting membrane trafficking defects in neurodegenerative diseases
-
21:30
new insights into disease mechanisms of genetic als
-
10:26
neuroimaging insights into the pathogenesis of umn-predominant als subtypes
-
40:22
expanding mechanisms and therapeutic targets for als
-
44:48
the expanding landscape of therapeutic targets in als clinical trials
-
1:17
recent advancements in investigational products for als
-
0:56
a new era in the discovery of als treatments
-
2:02
categorizing als to improve trial outcomes
-
1:36
fibrinolysis and trauma outcomes
-
1:31
debate around the treatment of ictal interictal continuum
-
3:31
every 90 minutes, someone is diagnosed with the als.
-
4:17
understanding als: the mystery behind lou gehrig's diseas
-
7:56
how is treatment effectiveness measured in als clinical trials?
-
2:42
exploring type1 prmt inhibitors in als
-
1:44
unanswered questions in als research
-
6:01
lost in translation: protein synthesis inhibition in als
-
59:30
imsa great minds program - dr. p. hande ozdinler